Last Updated : November 16, 2022
Details
FilesGeneric Name:
faricimab
Project Status:
Complete
Therapeutic Area:
Macular degeneration, age-related
Manufacturer:
Hoffmann-La Roche Ltd.
Brand Name:
Vabysmo
Project Line:
Reimbursement Review
Project Number:
SR0719-000
NOC Status at Filing:
Pre NOC
Performance Metric:
Achieved
Biosimilar:
No
Manufacturer Requested Reimbursement Criteria1:
For the treatment of Neovascular (wet) age-related macular degeneration (nAMD).
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
For the treatment of Neovascular (wet) age-related macular degeneration (nAMD).
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of Canada's Drug Agency. Reimbursement criteria from Canada's Drug Agency will be documented in the final recommendation, if applicable.
Key Milestones2 | |
|---|---|
| Call for patient/clinician input open | December 23, 2021 |
| Call for patient/clinician input closed | February 18, 2022 |
| Clarification: - Patient input submission received from Fighting Blindness Canada, The Canadian Council of the Blind, CNIB, Vision Loss Rehabilitation Canada | |
| Submission received | January 31, 2022 |
| Submission accepted | February 14, 2022 |
| Review initiated | February 17, 2022 |
| Draft CADTH review report(s) provided to sponsor for comment | May 04, 2022 |
| Deadline for sponsors comments | May 13, 2022 |
| CADTH review report(s) and responses to comments provided to sponsor | June 10, 2022 |
| Expert committee meeting (initial) | June 22, 2022 |
| Draft recommendation issued to sponsor | July 05, 2022 |
| Draft recommendation posted for stakeholder feedback | July 14, 2022 |
| End of feedback period | July 28, 2022 |
| Final recommendation issued to sponsor and drug plans | August 12, 2022 |
| Final recommendation posted | August 30, 2022 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | August 26, 2022 |
| CADTH review report(s) posted | November 16, 2022 |
Files
Last Updated : November 16, 2022